↓ Skip to main content

The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review

Overview of attention for article published in Orphanet Journal of Rare Diseases, April 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
6 X users
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
342 Dimensions

Readers on

mendeley
761 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review
Published in
Orphanet Journal of Rare Diseases, April 2017
DOI 10.1186/s13023-017-0631-3
Pubmed ID
Authors

S. Ryder, R. M. Leadley, N. Armstrong, M. Westwood, S. de Kock, T. Butt, M. Jain, J. Kleijnen

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 761 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 761 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 143 19%
Student > Master 79 10%
Student > Ph. D. Student 73 10%
Researcher 56 7%
Other 45 6%
Other 117 15%
Unknown 248 33%
Readers by discipline Count As %
Medicine and Dentistry 149 20%
Biochemistry, Genetics and Molecular Biology 96 13%
Nursing and Health Professions 56 7%
Agricultural and Biological Sciences 36 5%
Neuroscience 34 4%
Other 122 16%
Unknown 268 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 February 2022.
All research outputs
#1,275,051
of 25,837,817 outputs
Outputs from Orphanet Journal of Rare Diseases
#134
of 3,175 outputs
Outputs of similar age
#24,590
of 326,119 outputs
Outputs of similar age from Orphanet Journal of Rare Diseases
#7
of 54 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,175 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 326,119 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 54 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.